RDCA–DAP nets new data to speed research, therapies for CF - Cystic Fibrosis News Today
The RDCA-DAP, funded by the FDA and run by C-Path, has received new CF datasets from the Cystic Fibrosis Therapeutics Development Network, coordinated by Seattle Children’s Research Institute. These datasets aim to accelerate CF research and therapy development, enhancing the RDCA-DAP’s role in combating rare diseases.
Highlighted Terms
Related News
RDCA–DAP nets new data to speed research, therapies for CF - Cystic Fibrosis News Today
The RDCA-DAP, funded by the FDA and run by C-Path, has received new CF datasets from the Cystic Fibrosis Therapeutics Development Network, coordinated by Seattle Children’s Research Institute. These datasets aim to accelerate CF research and therapy development, enhancing the RDCA-DAP’s role in combating rare diseases.